These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 594116)

  • 1. [Optimization of the composition of tablets of phenylbutazone and aminophenazone by means of trial planning].
    Welikowa E; Jonowa R; Jontschew C
    Pharmazie; 1977; 32(8-9):502-4. PubMed ID: 594116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spectrophotometric analysis of phenylbutazone and aminopyrine in mixtures].
    Bagnarelli AE
    Rev Sanid Milit Argent; 1966; 65(1):92-8. PubMed ID: 5986739
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of phenylbutazone in addition to aminophenazone in drug preparations].
    Stájer G; Vinkler E; Szabó AE
    Pharmazie; 1970 Dec; 25(12):748-50. PubMed ID: 5499279
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of Henderson equation for the determination of weakly acidic pharmaceutical compounds. Part 3: Determination of phenylbutazone.
    El-Fatatry HM; Sharafel-Deen MM; Amer MM
    Pharmazie; 1979; 34(3):155-7. PubMed ID: 450955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of amidopyrine and butadion].
    Starostenko VE; Bubon NT
    Farmatsiia; 1971; 20(1):41-4. PubMed ID: 5581139
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of drug decomposition. Part 69: Effect of excipients on the thermal decomposition of the mixture of aminophenazone allobarbital and adiphenine hydrochloride in the solid.
    Pawełczyk E; Marciniec B
    Pharmazie; 1981 Aug; 36(8):540-2. PubMed ID: 6117089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mathematical optimization of the technology for preparing tablets containing amidopyrine and butadione].
    Doktorman RS; Groshovyĭ TA; Borzunov EE; Kozhakina IP; Koval' NA
    Farm Zh; 1977; (3):69-72. PubMed ID: 881027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of IR spectrophotometry in the quantitative analysis of drugs. IV. Assays of some compounded medicines].
    Pawełczyk E; Marciniec B
    Acta Pol Pharm; 1978; 35(6):643-8. PubMed ID: 742393
    [No Abstract]   [Full Text] [Related]  

  • 9. [The liberation of phenylbutazone from tablets].
    Miseta M; Hoang Hun Manh ; Pintye-Hódi K; Szabó-Révész P; Selmeczi B
    Pharmazie; 1988 Oct; 43(10):697-8. PubMed ID: 3212016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of excipients in tablets].
    Adam R; Bonnard J; De Herdt C; Denis E; Gloesener E; Soquet A; Van Haelen M
    J Pharm Belg; 1972; 27(4):442-56. PubMed ID: 4681076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kinetics of aminophenazone-clearance through blood exchange. A case of combined aminophenazone-phenylbutazone intoxication in a child].
    Windorfer A; Gädeke R; Schindera F
    Arch Toxikol; 1973 Mar; 30(3):237-42. PubMed ID: 4699974
    [No Abstract]   [Full Text] [Related]  

  • 12. The construction and uses of factorial designs in the preparation of solid dosage forms. Part 2: Granulation in a fluidized bed.
    Gorodnichev VI; El-Banna HM; Andreev BV
    Pharmazie; 1981 Apr; 36(4):270-3. PubMed ID: 7255528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pressure-course events in the tabletting of phenylbutazone].
    Wenzel U; Kala H
    Pharmazie; 1984 Oct; 39(10):693-4. PubMed ID: 6522447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gas chromatography determination of atropine, theophylline, phenobarbital and aminophenazone in tablets].
    Majlát P
    Pharmazie; 1984 May; 39(5):325-6. PubMed ID: 6473492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Method for the determination of phenylbutazone (FB) following chromatographic separation from isopyrine hydrochloride (I) and their decomposition production].
    Gołucki Z; Kobylińska-Luczko A
    Acta Pol Pharm; 1978; 35(2):233-6. PubMed ID: 665278
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of partial glycerides on the liberation of aminophenazone from suppositories].
    Bornschein M; Voigt R; Petri U
    Pharmazie; 1978 Sep; 33(9):591-3. PubMed ID: 733873
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of a matrix tablet formulation using a mixture design.
    Waaler PJ; Graffner C; Müller BW
    Acta Pharm Nord; 1992; 4(1):9-16. PubMed ID: 1515056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thin layer chromatography of derivatives of pyrazolone].
    Sarsúnová M; Kakác B
    Pharmazie; 1972 Jul; 27(7):447-8. PubMed ID: 5087238
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optimization of the composition of a multicomponent drug form by mathematical investigational designing and experimental testing (author's transl)].
    Jontschev C; Welikowa E
    Pharmazie; 1981; 36(1):32-4. PubMed ID: 7220583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Test methods and results of antipyretic drugs on simultaneous examination in 1966].
    Shibazaki T; Koibuchi M; Yamamoto M; Iahibashi M
    Eisei Shikenjo Hokoku; 1968; 86():161-3. PubMed ID: 5753664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.